Cannigma
Verified
Online/Digital
We want to be happy, relieve pain, and enjoy our lives. We usually turn to conventional medicine when things go wrong, but for some conditions western medicine has no good answers. So we’re left disappointed, without answers. And suffering.
But a new age is dawning. Scientific breakthroughs are happening at an unprecedented pace, and the stigma on a pretty remarkable plant is finally lifting, making cannabis available to people who need it most. That’s the story we want to dig into.
We’re here to help you find out about the healing properties of cannabis, how it can ease symptoms and speed up recovery. We’re committed to making sure this information is accessible to anyone who needs it — be it to relieve their own suffering, or that of their loved ones. Source
Actions
Media Outlet details
| Scope | International |
|---|---|
| Language | English |
| Country | N/A |
Similarweb UVM
|
Request pricing |
Comscore UVM
|
Request pricing |
Recent Articles
Search ArticlesThe Unexpected Frontline of Cannabinoid Medicine
Part 4 of the series: Why budtenders, purveyors, and frontline cannabis workers are being asked questions they were never fully trained to answer In the previous pieces, I explored why patients often feel overwhelmed navigating cannabinoid medicine and why many clinicians continue to be both curious and cautious as they try to responsibly work within a swiftly progressing field. But there is another group quietly positioned in the middle of all of this. Frontline cannabis workers and budtenders.
Federal Cannabis Reform Is Moving, but States Have a Fast-Approaching Deadline to Protect Patient Access
Medical cannabis policy is entering a new phase, and patients cannot afford for states to treat it like business as usual. For almost three decades, people who use cannabis therapeutically have had to balance conflicting laws and protections at the state and federal levels. That is finally starting to change.
What Consumers Should Expect When Visiting a Licensed Dispensary in Yonkers For the First Time
A visit to a licensed cannabis retailer can be an exciting experience for adults exploring Yonkers’ legal cannabis market. As the state’s adult-use program continues to expand across Westchester County and the NYC metro area, consumers have greater access to regulated products through approved locations. This growth has helped create a more accessible and informative purchasing experience. First-time visitors may feel more comfortable when they know what to expect before arriving.
Cannabis at the 2026 World Cup: What Every Fan Needs to Know
3 min read The 2026 FIFA World Cup is the most geographically ambitious tournament in history — 48 teams, 104 matches, and host cities spread across three countries: the United States, Canada, and Mexico. For the estimated five million fans descending on North America this summer, the question of cannabis is more complex than at any previous World Cup.
Why Eating Fat With THC Can Change Your Edible Experience
Everybody knows cannabis and fat go together. Cannabutter, infused oils, chocolates, brownies, gummies made with oil bases — fat is all throughout the cannabis edible world. Usually, that conversation stays pretty simple – cannabinoids like THC dissolve well in fat. And that is true. But fat may be doing more than helping us make edibles. It may also change how your body handles THC after you take it. That is the part I want to focus on here.
Ask The Green Nurse : Cannabis Nursing Is The Missing Link in Modern Healthcare
8 min read In healthcare settings across the nation, an increasing number of patients are turning to cannabis for therapeutic relief. While discussions with providers may not always be open, its application is widespread for managing conditions such as chronic pain, cancer symptoms, insomnia, anxiety, PTSD, autoimmune diseases, and neurological disorders, as well as providing end-of-life comfort.
Why So Many Clinicians Are Curious – Yet Still Hesitant
4 min read Part 3 of the series: Navigating cannabinoid medicine in a rapidly changing clinical landscape In the previous pieces, I explored the growing complexity surrounding chronic illness, cannabinoid-based therapeutics, and the increasing need for better educational frameworks for patients. Clinicians are navigating this changing landscape as well. And for many, the experience is complicated. Patient interest in cannabinoid medicine has expanded dramatically over the past decade.
DaySavers Drops Perfect Pack 2 Joint & Blunt Filling Machine
4 min read There’s a reason pre-rolls have become the dominant product in cannabis. They’re easy, they’re familiar and you don’t need to know how to roll. Just light up and go. In fact, according to the State of the Pre-Roll Market 2026 report from Custom Cones USA, pre-rolls overtook flower in 2025 to become the industry’s number one product by units sold, moving 383.2 million units and generating $3.6 billion in revenue.
A Cannabis Drug Just Beat Opioids in a Clinical Trial. Here’s What That Means.
2 min read For the first time in modern medicine, a cannabis-derived pharmaceutical has received regulatory approval in Europe — and it didn’t just prove effective. It outperformed opioids. On June 9, 2026, VERTANICAL, a biopharmaceutical company headquartered in Munich, Germany, announced that its drug Exilby® (VER-01) received marketing authorization in Germany for the treatment of chronic low back pain with a neuropathic component. Austria followed.
More Than Cannabis: A Story of Art and Gratitude
3 min read A Higher Note There is something about a card. Not a text. Not a quick emoji. A real, hold-it-in-your-hand, I thought of you kind of thing. Cannabis Cards Co. started there at the intersection of gifting and gratitude. Because giving something should feel just as good as receiving it. And honestly? Cannabis deserves better than the stigma it has been given over the years. This beautiful plant brings people together. It slows things down.